Loss of Asxl2 leads to myeloid malignancies in mice
ASXL2 mutations are mostly found in a subset of leukemia patients with certain genetic aberrations; however the role of this protein in normal hematopoiesis and related malignancies is still unclear. Here the authors use a knock-out mouse model to uncover the role of Asxl2in hematopoiesis and leukem...
Enregistré dans:
Auteurs principaux: | Jianping Li, Fuhong He, Peng Zhang, Shi Chen, Hui Shi, Yanling Sun, Ying Guo, Hui Yang, Na Man, Sarah Greenblatt, Zhaomin Li, Zhengyu Guo, Yuan Zhou, Lan Wang, Lluis Morey, Sion Williams, Xi Chen, Qun-Tian Wang, Stephen D. Nimer, Peng Yu, Qian-Fei Wang, Mingjiang Xu, Feng-Chun Yang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d8d0621e6a8f4b58bd9d7e748569e036 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
par: Shuhei Asada, et autres
Publié: (2018) -
Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1
par: Salima Daou, et autres
Publié: (2018) -
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia
par: Ganqian Zhu, et autres
Publié: (2021) -
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
par: Jean-Baptiste Micol, et autres
Publié: (2017) -
BAP1/ASXL1 recruitment and activation for H2A deubiquitination
par: Danny D. Sahtoe, et autres
Publié: (2016)